.png)
Obesity Treatment Market by Drugs and Devices and Surgery - Global Industry Analysis and Forecast to 2027
Published On : September 2017 Pages : 130 Category: Medical Devices Report Code : HC06102
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Trend Analysis
Obesity treatment market is expected to experience an average growth in coming years between 2022 and 2027. The market is expected to become $0.81 billion by 2027 at a slow CAGR of %. The technological advancement to improve compliance rates of surgeries, Government initiatives to increase awareness about fitness among people and aggressive promotional activities to attract customers will be the major driving factors of obesity treatment market. Obesity has become a common phenomenon across the globe in all age groups. For instance, as per survey, in US, adult obesity rates has exceeded more than % in five states, more than % in 26 states and more than % in 48 states in 2017. This trend gives an indication of increase in demand of obesity treatment in the upcoming years. However, successful treatment of obesity and overweight requires lifelong effort for making permanent changes in both energy intake and expenditure. As a result, people fail to continue with the treatment due to high cost and prefer to opt for low cost alternatives which are easily available in the market. In addition, post-surgical side effects and high cost of customization will also restrain the growth of the market over the forecast period. Even the key players of the market avoid taking risk of innovation as the chance of return on investments is very low. Thus, considering all these drivers and challenges, obesity treatment market is expected to witness average growth in the upcoming years.
Obesity Treatment Surgery Outlook and Trend Analysis
Obesity can be effectively managed through surgical and non-surgical methods such as use of drugs and making changes in lifestyle. Weight loss drugs including diethylpropion and lorcaserin alter the way by which brain regulates urge to eat leading to decreased appetite. These medicines along with lifestyle changes results in effective weight loss. Surgical fat removal procedures such as Gastric bypass surgery are used when patients doesn’t respond to drugs or lifestyle changes. During surgical procedure, small part of stomach is connected to intestine to decrease the amount of fat body can take or store, leading to weight loss.
Regional Outlook and Trend Analysis
North America held a significant share of the obesity treatment market in 2017 due to the increase in obesity cases in various states. In addition, increase in disposable income has also led to more adoption of obesity treatment by people. The Asia-Pacific market has not experienced any substantial growth due to lack of large scale adoption of advanced treatment for obesity management but can experience favorable growth in coming years owing to increasing awareness and changing lifestyles related to obesity management in the region.
Competitive Outlook and Trend Analysis
The key players operating in the global obesity treatment market emphasize on product development in order to introduce improve obesity treatment and capture a larger share of the market. Some of the major players in this market are, Allergan Plc, Medtronic, VIVUS, Inc., Atkins Nutritionals, Inc., EnteroMedics, Inc, F. Hoffmann-La Roche Ltd., Apollo Endosurgery, Inc., Novo Nordisk A/S, USGI Medical, Inc., Ethicon (subsidiary of Johnson & Johnson), Herbalife Ltd., Cousin Biotech, Johnson Health Technology, Ltd., Orexigen Therapeutics, and Technogym Spa.
Market Opportunities
The key opportunity for the players operating in obesity treatment market lies in the development of various types of drugs and surgical devices for treatment and also increasing awareness towards obesity. Apart from that, innovative marketing strategies will further broaden the opportunities of the key players to grow significantly over the forecast period. In addition, manufacturing of budget efficient carbohydrate diet for obesity, will further increase demand of this market, creating a lucrative opportunities for growth, for the key players of this market.
Global Obesity Treatment Market Segmentation:
By Drugs
- Appetite Suppressants
- Satiety
- Combination Drugs
- Malabsorption
By Devices and Surgery
- Roux-en-Y Gastric Bypass
- Biliopancreatic Diversion with Duodenal Switch
- Adjusting Gastric Banding
- Sleeve Gastrostomy
- Endoscopic Procedures
- Others
By Region
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- United Arab Emirates
- Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2022 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
- Obesity Treatment Market, By Drugs, Estimates and Forecast, 2017-2027 ($Million)
- Appetite Suppressants
- Satiety
- Combination Drugs
- Malabsorption
- Obesity Treatment Market, By Devices and Surgery, Estimates and Forecast, 2017-2027 ($Million)
- Roux-en-Y Gastric Bypass
- Biliopancreatic Diversion with Duodenal Switch
- Adjusting Gastric Banding
- Sleeve Gastrostomy
- Endoscopic Procedures
- Others
- Obesity Treatment Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
- North America
- North America Obesity Treatment Market, By Country
- North America Obesity Treatment Market, By Drugs
- North America Obesity Treatment Market, By Devices and Surgery
- U.S. Obesity Treatment Market, By Drugs
- U.S. Obesity Treatment Market, By Devices and Surgery
- Canada Obesity Treatment Market, By Drugs
- Canada Obesity Treatment Market, By Devices and Surgery
- Mexico Obesity Treatment Market, By Drugs
- Mexico Obesity Treatment Market, By Devices and Surgery
-
- Europe
- Europe Obesity Treatment Market, By Country
- Europe Obesity Treatment Market, By Drugs
- Europe Obesity Treatment Market, By Devices and Surgery
- Germany Obesity Treatment Market, By Drugs
- Germany Obesity Treatment Market, By Devices and Surgery
- France Obesity Treatment Market, By Drugs
- France Obesity Treatment Market, By Devices and Surgery
- UK Obesity Treatment Market, By Drugs
- UK Obesity Treatment Market, By Devices and Surgery
- Italy Obesity Treatment Market, By Drugs
- Italy Obesity Treatment Market, By Devices and Surgery
- Spain Obesity Treatment Market, By Drugs
- Spain Obesity Treatment Market, By Devices and Surgery
- Rest of Europe Obesity Treatment Market, By Drugs
- Rest of Europe Obesity Treatment Market, By Devices and Surgery
-
- Asia-Pacific
- Asia-Pacific Obesity Treatment Market, By Country
- Asia-Pacific Obesity Treatment Market, By Drugs
- Asia-Pacific Obesity Treatment Market, By Devices and Surgery
- Japan Obesity Treatment Market, By Drugs
- Japan Obesity Treatment Market, By Devices and Surgery
- Australia Obesity Treatment Market, By Drugs
- Australia Obesity Treatment Market, By Devices and Surgery
- India Obesity Treatment Market, By Drugs
- India Obesity Treatment Market, By Devices and Surgery
- South Korea Obesity Treatment Market, By Drugs
- South Korea Obesity Treatment Market, By Devices and Surgery
- Rest of Asia-Pacific Obesity Treatment Market, By Drugs
- Rest of Asia-Pacific Obesity Treatment Market, By Devices and Surgery
- Asia-Pacific
-
- Rest of the World
- Rest of the World Obesity Treatment Market, By Country
- Rest of the World Obesity Treatment Market, By Drugs
- Rest of the World Obesity Treatment Market, By Devices and Surgery
- Brazil Obesity Treatment Market, By Drugs
- Brazil Obesity Treatment Market, By Devices and Surgery
- South Africa Obesity Treatment Market, By Drugs
- South Africa Obesity Treatment Market, By Devices and Surgery
- Saudi Arabia Obesity Treatment Market, By Drugs
- Saudi Arabia Obesity Treatment Market, By Devices and Surgery
- Turkey Obesity Treatment Market, By Drugs
- Turkey Obesity Treatment Market, By Devices and Surgery
- United Arab Emirates Obesity Treatment Market, By Drugs
- United Arab Emirates Obesity Treatment Market, By Devices and Surgery
- Others Obesity Treatment Market, By Drugs
- Others Obesity Treatment Market, By Devices and Surgery
- Rest of the World
Table of Contents
1.Introduction
1.1.Report Description
1.2.Research Methodology
2.Executive Summary
2.1.Key Highlights
3.Market Overview
3.1.Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2.Market Share Analysis
3.3.Market Dynamics
3.3.1. Drivers
3.3.1.1.Increasing cases of Obesity across the Globe
3.3.1.2.Increasing disposable income and changing lifestyles
3.3.2. Restraints
3.3.2.1.High Cost of Obesity Treatment Devices and Drugs
3.3.2.2.Risk of Post-Surgical Side-Effects
3.3.2.3.Availability of Low Cost Alternatives
3.3.3. Opportunities
3.3.3.1.Emerging Markets to Offer Lucrative Growth Opportunities
3.4.Industry Trends
4.Obesity Treatment Market, By Drugs
4.1.Introduction
4.2.Obesity Treatment Market Assessment and Forecast, By Drugs, 2017-2027
4.3.Appetite Suppressants
4.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.Satiety
4.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.5.Combination Drugs
4.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.6.Malabsorption
4.6.1. Market Assessment and Forecast, By Region, 2017-2027
5.Obesity Treatment Market, By Devices and Surgery
5.1.Introduction
5.2.The Obesity Treatment Market Assessment and Forecast, By Devices and Surgery, 2017-2027
5.3.Roux-en-YGastric Bypass
5.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.4.Biliopancreatic Diversion with Duodenal Switch
5.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.5.Adjusting Gastric Banding
5.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.6.Sleeve Gastronomy
5.6.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.7.Endoscopic Procedures
5.7.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.8.Others
5.8.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.Obesity Treatment Market, By Region
6.1.Introduction
6.2.Obesity Treatment Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.3.Obesity Treatment Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.4.North America
6.4.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.4.2. Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.4.3. Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.4.4. U.S.
6.4.4.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.4.4.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.4.5. Canada
6.4.5.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.4.5.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.4.6. Mexico
6.4.6.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.4.6.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.5.Europe
6.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.5.2. Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.5.3. Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.5.4. Germany
6.5.4.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.5.4.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.5.5. France
6.5.5.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.5.5.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.5.6. UK
6.5.6.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.5.6.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.5.7. Italy
6.5.7.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.5.7.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.5.8. Spain
6.5.8.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.5.8.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.5.9. Russia
6.5.9.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.5.9.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.5.10.Rest of Europe
6.5.10.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.5.10.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.6.Asia-Pacific
6.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.6.2. Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.6.3. Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.6.4. Japan
6.6.4.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.6.4.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.6.5. China
6.6.5.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.6.5.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.6.6. Australia
6.6.6.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.6.6.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.6.7. India
6.6.7.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.6.7.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.6.8. South Korea
6.6.8.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.6.8.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.6.9. Taiwan
6.6.9.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.6.9.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.6.10.Rest of Asia-Pacific
6.6.10.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.6.10.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.7.Rest of the World
6.7.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.7.2. Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.7.3. Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.7.4. Brazil
6.7.4.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.7.4.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.7.5. Turkey
6.7.5.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.7.5.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.7.6. Saudi Arabia
6.7.6.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.7.6.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.7.7. South Africa
6.7.7.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.7.7.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.7.8. United Arab Emirates
6.7.8.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.7.8.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
6.7.9. Others
6.7.9.1.Market Assessment and Forecast, By Drugs, 2017-2027 ($Million)
6.7.9.2.Market Assessment and Forecast, By Devices and Surgery, 2017-2027 ($Million)
7.Company Profiles
7.1.VIVUS, Inc.
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Key Financials
7.1.4. Strategic Developments
7.2.F. Hoffmann-La Roche Ltd
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Key Financials
7.2.4. Strategic Developments
7.3.Novo Nordisk A/S
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Key Financials
7.3.4. Strategic Developments
7.4.Allergan Plc
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Key Financials
7.4.4. Strategic Developments
7.5.Medtronic
7.5.1. Business Overview
7.5.2. Product Portfolio
7.5.3. Key Financials
7.5.4. Strategic Developments
7.6.Ethicon (subsidiary of Johnson & Johnson)
7.6.1. Business Overview
7.6.2. Product Portfolio
7.6.3. Strategic Developments
7.7.Cousin Biotech
7.7.1. Business Overview
7.7.2. Product Portfolio
7.7.3. Strategic Developments
7.8.EnteroMedics, Inc.
7.8.1. Business Overview
7.8.2. Product Portfolio
7.8.3. Key Financials
7.8.4. Strategic Developments
7.9.USGI Medical
7.9.1. Business Overview
7.9.2. Product Portfolio
7.9.3. Strategic Developments
7.10.Orexigen Therapeutics
7.10.1.Business Overview
7.10.2.Product Portfolio
7.10.3.Key Financials
7.10.4.Strategic Developments
7.11.Atkins Nutritionals
7.11.1.Business Overview
7.11.2.Product Portfolio
7.11.3.Strategic Developments
7.12.Herbalife Ltd.
7.12.1. Business Overview
7.12.2.Product Portfolio
7.12.3.Key Financials
7.12.4.Strategic Developments
7.13.Apollo Endosurgery, Inc.
7.13.1.Business Overview
7.13.2.Product Portfolio
7.13.3.Key Financials
7.13.4.Strategic Developments
7.14.Johnson Health Technology, Ltd.
7.14.1.Business Overview
7.14.2.Product Portfolio
7.14.3.Strategic Developments
7.15.Technogym Spa
7.15.1.Business Overview
7.15.2.Product Portfolio
7.15.3.Strategic Developments
List of Tables
Table 1.Global Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 2.Apetitite Suppressants Market, By Region, 2017-2025 ($Million)
Table 3.Satiety Market, By Region, 2017-2025 ($Million)
Table 4.Combination Drugs Market, By Region, 2017-2025 ($Million)
Table 5.Malabsorption Market, By Region, 2017-2025 ($Million)
Table 6.Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 7.Roux-en-Y Gastric Bypass Market, By Region, 2017-2025 ($Million)
Table 8.Biliopancreatic Diversion with Duodenal Switch Market, By Region, 2017-2025 ($Million)
Table 9.Adjusting Gastric Banding Market, By Region, 2017-2025 ($Million)
Table 10.Sleeve Gastrostomy Market, By Region, 2017-2025 ($Million)
Table 11.Endoscopic Procedures Market, By Region, 2017-2025 ($Million)
Table 12.Others Market, By Region, 2017-2025 ($Million)
Table 13.North America Obesity Treatment Market, By Country, 2017-2025 ($Million)
Table 14.North America Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 15.North America Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 16.U.S. Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 17.U.S. Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 18.Canada Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 19.Canada Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 20.Mexico Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 21.Mexico Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 22.Europe Obesity Treatment Market, By Country, 2017-2025 ($Million)
Table 23.Europe Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 24.Europe Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 25.Germany Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 26.Germany Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 27.France Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 28.France Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 29.UK Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 30.UK Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 31.Italy Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 32.Italy Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 33.Spain Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 34.Spain Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 35.Russia Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 36.Russia Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 37.Rest of Europe Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 38.Rest of Europe Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 39.Asia-Pacific Obesity Treatment Market, By Country, 2017-2025 ($Million)
Table 40.Asia-Pacific Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 41.Asia-Pacific Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 42.Japan Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 43.Japan Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 44.China Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 45.China Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 46.Australia Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 47.Australia Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 48.India Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 49.India Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 50.South Korea Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 51.South Korea Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 52.Rest of Asia-Pacific Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 53.Rest of Asia-Pacific Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 54.Rest of the World Obesity Treatment Market, By Country, 2017-2025 ($Million)
Table 55.Rest of the World Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 56.Rest of the World Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 57.Brazil Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 58.Brazil Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 59.Turkey Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 60.Turkey Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 61.Saudi Arabia Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 62.Saudi Arabia Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 63.South Africa Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 64.South Africa Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 65.United Arab Emirates Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 66.United Arab Emirates Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 67.Others Obesity Treatment Market, By Drugs, 2017-2025 ($Million)
Table 68.Others Obesity Treatment Market, By Devices and Surgery, 2017-2025 ($Million)
Table 69.VIVUS, Inc.: Key Strategic Developments, 2017-2017
Table 70.F. Hoffmann-La Roche Ltd.: Key Strategic Developments, 2017-2017
Table 71.Novo Nordisk A/S: Key Strategic Developments, 2017-2017
Table 72.Allergan Plc: Key Strategic Developments, 2017-2017
Table 73.Medtronic: Key Strategic Developments, 2017-2017
Table 74.Ethicon (subsidiary of Johnson & Johnson): Key Strategic Developments, 2017-2017
Table 75.Cousin Biotech: Key Strategic Developments, 2017-2017
Table 76.EnteroMedics, Inc: Key Strategic Developments, 2017-2017
Table 77.USGI Medical: Key Strategic Developments, 2017-2017
Table 78.Orexigen Therapeutics: Key Strategic Developments, 2017-2017
Table 79.Atkins Nutritionals: Key Strategic Developments, 2017-2017
Table 80.Herbalife Ltd: Key Strategic Developments, 2017-2017
Table 81.Apollo Endosurgery, Inc.: Key Strategic Developments, 2017-2017
Table 82.Johnson Health Technology Ltd: Key Strategic Developments, 2017-2017
Table 83.Technogym Spa: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.GlobaObesity Treatment Market Share, By Drugs, 2017 & 2025
Figure 2.Obesity Treatment Market, By Devices and Surgery, 2017, ($Million)
Figure 3.Obesity Treatment Market, By Region, 2017, ($Million)
Figure 4.VIVUS, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 5.VIVUS, Inc.: Net Revenue Share, By Segment, 2017
Figure 6.VIVUS, Inc.: Net Revenue Share, By Geography, 2017
Figure 7.F. Hoffmann-La Roche Ltd: Net Revenues, 2017-2017 ($Million)
Figure 8.F. Hoffmann-La Roche Ltd: Net Revenue Share, By Segment, 2017
Figure 9.F. Hoffmann-La Roche Ltd: Net Revenue Share, By Geography, 2017
Figure 10.Novo Nordisk A/S: Net Revenues, 2017-2017 ($Million)
Figure 11.Novo Nordisk A/S.: Net Revenue Share, By Segment, 2017
Figure 12.Novo Nordisk A/S: Net Revenue Share, By Geography, 2017
Figure 13.Allergan Plc: Net Revenues, 2017-2017 ($Million)
Figure 14.Allergan Plc: Net Revenue Share, By Segment, 2017
Figure 15.Allergan Plc: Net Revenue Share, By Geography, 2017
Figure 16.Medtronic: Net Revenues, 2017-2017 ($Million)
Figure 17.Medtronic: Net Revenue Share, By Segment, 2017
Figure 18.Medtronic: Net Revenue Share, By Geography, 2017
Figure 19.EnteroMedics,Inc Net Revenues, 2017-2017 ($Million)
Figure 20.EnteroMedics,Inc Net Revenue Share, By Segment, 2017
Figure 21.EnteroMedics,Inc: Net Revenue Share, By Geography, 2017
Figure 22.Orexigen Therapeutics: Net Revenues, 2017-2017 ($Million)
Figure 23.Orexigen Therapeutics: Net Revenue Share, By Segment, 2017
Figure 24.Orexigen Therapeutics: Net Revenue Share, By Geography, 2017
Figure 25.Herbalife Ltd: Net Revenues, 2017-2017 ($Million)
Figure 26.Herbalife Ltd: Net Revenue Share, By Segment, 2017
Figure 27.Herbalife Ltd: Net Revenue Share, By Geography, 2017
Figure 28.Apollo Endosurgery, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 29.Apollo Endosurgery, Inc.: Net Revenue Share, By Segment, 2017
Figure 30.Apollo Endosurgery, Inc.: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|